These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15197278)

  • 1. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel.
    Levin AD; Vukmirovic N; Hwang CW; Edelman ER
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9463-7. PubMed ID: 15197278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and systemic drug competition in drug-eluting stent tissue deposition properties.
    Levin AD; Jonas M; Hwang CW; Edelman ER
    J Control Release; 2005 Dec; 109(1-3):236-43. PubMed ID: 16289420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial paclitaxel distribution and deposition.
    Creel CJ; Lovich MA; Edelman ER
    Circ Res; 2000 Apr; 86(8):879-84. PubMed ID: 10785510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion complexity determines arterial drug distribution after local drug delivery.
    Tzafriri AR; Vukmirovic N; Kolachalama VB; Astafieva I; Edelman ER
    J Control Release; 2010 Mar; 142(3):332-8. PubMed ID: 19925836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall.
    Bozsak F; Chomaz JM; Barakat AI
    Biomech Model Mechanobiol; 2014 Apr; 13(2):327-47. PubMed ID: 24395527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.
    Pires NM; Eefting D; de Vries MR; Quax PH; Jukema JW
    Heart; 2007 Aug; 93(8):922-7. PubMed ID: 17449502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices.
    Alexis F; Venkatraman SS; Rath SK; Boey F
    J Control Release; 2004 Jul; 98(1):67-74. PubMed ID: 15245890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
    Mehilli J; Kastrati A; Wessely R; Dibra A; Hausleiter J; Jaschke B; Dirschinger J; Schömig A;
    Circulation; 2006 Jan; 113(2):273-9. PubMed ID: 16391155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design.
    Wessely R; Kastrati A; Mehilli J; Dibra A; Pache J; Schömig A
    Eur Heart J; 2007 Nov; 28(22):2720-5. PubMed ID: 17921531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial pharmacokinetics of red wine polyphenols: implications for novel endovascular therapies targeting restenosis.
    Kleinedler JJ; Pjescic I; Bullock KK; Khaliq A; Foley JD; Dugas TR
    J Pharm Sci; 2012 May; 101(5):1917-31. PubMed ID: 22359273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different.
    Wessely R; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Feb; 47(4):708-14. PubMed ID: 16487832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel.
    Lovich MA; Creel C; Hong K; Hwang CW; Edelman ER
    J Pharm Sci; 2001 Sep; 90(9):1324-35. PubMed ID: 11745785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
    Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-induced arterial wall toxicity and inflammation: tissue uptake in various dose densities in a minipig model.
    Radeleff B; Lopez-Benitez R; Stampfl U; Stampfl S; Sommer C; Thierjung H; Berger I; Kauffmann G; Richter GM
    J Vasc Interv Radiol; 2010 Aug; 21(8):1262-70. PubMed ID: 20656224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of lesions with a high risk of stenosis. Comparative study in 300 patients of rapamycin- and Paclitaxel-eluting polymer-based stents, and bare metal stents].
    de la Torre Hernández JM; Sainz Laso F; Ruisánchez C; Zueco J; Figueroa A; Colman T
    Rev Esp Cardiol; 2005 Mar; 58(3):262-9. PubMed ID: 15766448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis modulates arterial drug distribution for drug-eluting stents.
    Hwang CW; Levin AD; Jonas M; Li PH; Edelman ER
    Circulation; 2005 Apr; 111(13):1619-26. PubMed ID: 15795325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?
    Buellesfeld L; Grube E
    Herz; 2004 Mar; 29(2):167-70. PubMed ID: 15054589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.